from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2334/cysK1

LFCtreatmentdescriptionclass of inhibitor

-1.154

Amikacinug/mL Amikacintranslation

-0.718

Cap5-10ug/mL Capreomycintranslation

-1.405

Rox10-50 ug/mL Roxithromycintranslation

0.587

SM2-5 ug/mL Streptomycintranslation

-0.653

Tet5-10 ug/mL Tetracyclinetranslation

-0.343

Rif0.2-5ug/mL Rifampicintranscription

-1.315

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.877

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.547

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.495

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.066

Clofazimine10-13 ug/mL Clofaziminerespiration

0.403

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.719

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.703

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.122

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.362

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.164

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.931

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.910

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.997

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.291

KCN5-20 ug/mL Potassium cyaniderespiration

1.170

NaN30.2-2 mM Sodium aziderespiration

-0.345

Nigericin50 uM Nigericinrespiration

-0.063

TRC10-150 ug/mL Triclosanrespiration

-1.378

TRZ10-25 ug/mL Thioridazinerespiration

-2.020

Valinomycin0.5-10 uM Valinomycinrespiration

0.097

ZnSO42 mM ZnSO4respiration

0.659

menadione6-10 ug/mL Menadionerespiration

-0.442

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.227

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.179

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.336

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.567

NRP_1Non-replicating persistence stage 1dosRassociated

0.265

Amp0.2mg/mL AmpicillincellWall

0.247

Cephalexin20-100 ug/mL CephalexincellWall

-0.018

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.340

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.618

EMB10-20 ug/mL EthambutolcellWall

-0.157

Eta12-40 ug/mL EthionamidecellWall

0.144

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.613

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.606

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.082

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.217

BZA0.12 mg/mL BenzamidearomaticAmides

-0.447

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.576

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.421

H2O24 mM hydrogen peroxideDNAdamaging

-0.654

Levo10 ug/mL LevofloxacinDNAdamaging

0.891

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.336

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.083

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.597

UVUV-irradiationDNAdamaging

1.055

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.156

Antimycin12.5-50 ug/mL Antimycin A?

0.287

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.182

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.149

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.502

PA8240.2-2 ug/mL PA-824?

1.291

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.791

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.061

Verapamil50 uM Verapamil?

-0.041

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.013

methoxatin10-20 ug/mL Methoxatin?